Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors.

Autor: Takeuchi, Eiji1 (AUTHOR) eijitake1964@icloud.com, Kondo, Kensuke2 (AUTHOR), Okano, Yoshio3 (AUTHOR), Ichihara, Seiya3 (AUTHOR), Kunishige, Michihiro3 (AUTHOR), Kadota, Naoki3 (AUTHOR), Machida, Hisanori3 (AUTHOR), Hatakeyama, Nobuo3 (AUTHOR), Naruse, Keishi4 (AUTHOR), Ogino, Hirokazu2 (AUTHOR), Nokihara, Hiroshi2 (AUTHOR), Shinohara, Tsutomu5 (AUTHOR), Nishioka, Yasuhiko2 (AUTHOR)
Zdroj: Thoracic Cancer. Oct2023, Vol. 14 Issue 30, p3042-3050. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje